145 related articles for article (PubMed ID: 34141843)
1. Electroretinography data from ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinoses.
Russell KN; Mitchell NL; Wellby MP; Barrell GK; Palmer DN
Data Brief; 2021 Aug; 37():107188. PubMed ID: 34141843
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal gene therapy protects against retinal dysfunction and degeneration in sheep with CLN5 Batten disease.
Murray SJ; Russell KN; Melzer TR; Gray SJ; Heap SJ; Palmer DN; Mitchell NL
Exp Eye Res; 2021 Jun; 207():108600. PubMed ID: 33930398
[TBL] [Abstract][Full Text] [Related]
3. Natural history of retinal degeneration in ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinoses.
Murray SJ; Mitchell NL
Sci Rep; 2022 Mar; 12(1):3670. PubMed ID: 35256654
[TBL] [Abstract][Full Text] [Related]
4. Progressive MRI brain volume changes in ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinosis.
Murray SJ; Almuqbel MM; Felton SA; Palmer NJ; Myall DJ; Shoorangiz R; Ella A; Keller M; Palmer DN; Melzer TR; Mitchell NL
Brain Commun; 2023; 5(1):fcac339. PubMed ID: 36632184
[TBL] [Abstract][Full Text] [Related]
5. Computed tomography provides enhanced techniques for longitudinal monitoring of progressive intracranial volume loss associated with regional neurodegeneration in ovine neuronal ceroid lipofuscinoses.
Russell KN; Mitchell NL; Anderson NG; Bunt CR; Wellby MP; Melzer TR; Barrell GK; Palmer DN
Brain Behav; 2018 Sep; 8(9):e01096. PubMed ID: 30136763
[TBL] [Abstract][Full Text] [Related]
6. Characterization of neuropathology in ovine CLN5 and CLN6 neuronal ceroid lipofuscinoses (Batten disease).
Mitchell NL; Russell KN; Barrell GK; Tammen I; Palmer DN
Dev Neurobiol; 2023; 83(5-6):127-142. PubMed ID: 37246363
[TBL] [Abstract][Full Text] [Related]
7. A missense mutation (c.184C>T) in ovine CLN6 causes neuronal ceroid lipofuscinosis in Merino sheep whereas affected South Hampshire sheep have reduced levels of CLN6 mRNA.
Tammen I; Houweling PJ; Frugier T; Mitchell NL; Kay GW; Cavanagh JA; Cook RW; Raadsma HW; Palmer DN
Biochim Biophys Acta; 2006 Oct; 1762(10):898-905. PubMed ID: 17046213
[TBL] [Abstract][Full Text] [Related]
8. Recent studies of ovine neuronal ceroid lipofuscinoses from BARN, the Batten Animal Research Network.
Palmer DN; Neverman NJ; Chen JZ; Chang CT; Houweling PJ; Barry LA; Tammen I; Hughes SM; Mitchell NL
Biochim Biophys Acta; 2015 Oct; 1852(10 Pt B):2279-86. PubMed ID: 26073432
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of early changes in ovine CLN5 and CLN6 Batten disease neural cultures for the rapid screening of therapeutics.
Best HL; Neverman NJ; Wicky HE; Mitchell NL; Leitch B; Hughes SM
Neurobiol Dis; 2017 Apr; 100():62-74. PubMed ID: 28065762
[TBL] [Abstract][Full Text] [Related]
10. An EEG Investigation of Sleep Homeostasis in Healthy and CLN5 Batten Disease Affected Sheep.
Perentos N; Martins AQ; Cumming RJ; Mitchell NL; Palmer DN; Sawiak SJ; Morton AJ
J Neurosci; 2016 Aug; 36(31):8238-49. PubMed ID: 27488642
[TBL] [Abstract][Full Text] [Related]
11. Genetics of the neuronal ceroid lipofuscinoses (Batten disease).
Mole SE; Cotman SL
Biochim Biophys Acta; 2015 Oct; 1852(10 Pt B):2237-41. PubMed ID: 26026925
[TBL] [Abstract][Full Text] [Related]
12. Experimental Therapeutic Approaches for the Treatment of Retinal Pathology in Neuronal Ceroid Lipofuscinoses.
Bartsch U; Storch S
Front Neurol; 2022; 13():866983. PubMed ID: 35509995
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal In Vivo Monitoring of the CNS Demonstrates the Efficacy of Gene Therapy in a Sheep Model of CLN5 Batten Disease.
Mitchell NL; Russell KN; Wellby MP; Wicky HE; Schoderboeck L; Barrell GK; Melzer TR; Gray SJ; Hughes SM; Palmer DN
Mol Ther; 2018 Oct; 26(10):2366-2378. PubMed ID: 30078766
[TBL] [Abstract][Full Text] [Related]
14. Long-term safety and dose escalation of intracerebroventricular CLN5 gene therapy in sheep supports clinical translation for CLN5 Batten disease.
Mitchell NL; Murray SJ; Wellby MP; Barrell GK; Russell KN; Deane AR; Wynyard JR; Palmer MJ; Pulickan A; Prendergast PM; Casy W; Gray SJ; Palmer DN
Front Genet; 2023; 14():1212228. PubMed ID: 37614821
[TBL] [Abstract][Full Text] [Related]
15. Cell biology of the NCL proteins: What they do and don't do.
Cárcel-Trullols J; Kovács AD; Pearce DA
Biochim Biophys Acta; 2015 Oct; 1852(10 Pt B):2242-55. PubMed ID: 25962910
[TBL] [Abstract][Full Text] [Related]
16. A lysosomal enigma CLN5 and its significance in understanding neuronal ceroid lipofuscinosis.
Basak I; Wicky HE; McDonald KO; Xu JB; Palmer JE; Best HL; Lefrancois S; Lee SY; Schoderboeck L; Hughes SM
Cell Mol Life Sci; 2021 May; 78(10):4735-4763. PubMed ID: 33792748
[TBL] [Abstract][Full Text] [Related]
17. Chronic oral administration of minocycline to sheep with ovine CLN6 neuronal ceroid lipofuscinosis maintains pharmacological concentrations in the brain but does not suppress neuroinflammation or disease progression.
Kay GW; Palmer DN
J Neuroinflammation; 2013 Jul; 10():97. PubMed ID: 23899308
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of storage pathology in prenatal CLN5-deficient sheep neural cultures by lentiviral gene therapy.
Hughes SM; Hope KM; Xu JB; Mitchell NL; Palmer DN
Neurobiol Dis; 2014 Feb; 62():543-50. PubMed ID: 24269732
[TBL] [Abstract][Full Text] [Related]
19. Retention of lysosomal protein CLN5 in the endoplasmic reticulum causes neuronal ceroid lipofuscinosis in Asian sibship.
Lebrun AH; Storch S; Rüschendorf F; Schmiedt ML; Kyttälä A; Mole SE; Kitzmüller C; Saar K; Mewasingh LD; Boda V; Kohlschütter A; Ullrich K; Braulke T; Schulz A
Hum Mutat; 2009 May; 30(5):E651-61. PubMed ID: 19309691
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
